Home › NCT06239818
Assessing the Effects of Photobiomodulation on Clinical Recovery From Concussion in Adolescents
Recruiting
Who can join
Ages 13 to 18 · All sexes
Full eligibility criteria
Inclusion Criteria: * current participants in a school- or club-sponsored sport (contact or non-contact) * access to wireless internet service at home * diagnosis of sports-related concussion (SRC) (according to consensus diagnostic criteria) by a licensed healthcare provider,3-7 days from the concussive injury at the time of enrolment * considered at-risk for protracted recovery based on Immediate Post-concussion Assessment and Cognitive Testing (ImPACT) performance and symptom reporting on the Post-Concussion Symptom Scale (PCSS) Exclusion Criteria: * acute neurologic deterioration to a Glasgow Coma Scale score less than 13 * neurosurgical intervention * abnormal CT scan * concomitant extracranial injury worse than mild * pre-injury conditions which confound effects of SRC (e.g., epilepsy, schizophrenia, bipolar illness, mental deficiency, hospitalization for TBI) * substance dependence * inability to speak fluent English * Individuals who are taking benzodiazepines, anti-convulsants, mood stabilizers, stimulants, opioids, sleep aids, or other neuropsychiatric medications
About the study
The purpose of this study is to compare effects of Photobiomodulation therapy (PBMt) to standard of care in adolescent athletes at risk for delayed recovery from subacute sports concussion, to substantiate the impact of subacute PBMt over time on functional and structural connectivity of the brain using advanced MRI sequences and to correlate the psychological and behavioral outcomes to neuroimaging findings
What is being tested
- Photobiomodulation therapy (PBMt) (device)
- Standard of Care (other)
Sponsor: The University of Texas Health Science Center, Houston · Participants: 30 · Started: Apr 17, 2024
Contact the study team
- Summer Ott, PsyD · Phone: (713) 486-3435
Official record on ClinicalTrials.gov — NCT06239818
Locations in the U.S.
| Texas | The University of Texas Health Science Center at Houston, Houston |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.